4 MEIP's, page-92

Even many of the longs here, could be in for a big surprise as to the extent of movement in the share price. I would look for some big action this week, or at least in the near term.

Anyway back to MEI Pharma. Here is a two week old presentation from the CEO, on you tube. (See link at very bottom. ) He provides discussion on how their ME344 drug (superseded by Cantrixil - my words) kills breast cancer tumors, in conjunction with the big selling chemo drug Avastin . This presentation follows release of results of human trials this year.

Of most significance though, for the first time, we are provided an explanation as to how ME344 will work to compliment ALL other chemo drug........CEO comment- ME344 is a ....." general way of going after" cancer.

Yes thats what he is saying, for use to compliment all other chemo drugs. Go to 22.30 seconds in the video and listen for yourself. Its worth it.

All the work done in the clinic by Dr Mor at Yale, is now being confirmed in Phase 1 human trials.

It is easy to be very excited here for KZA, based on real data.

I think the reaction to the info released by Dr Gold has been muted in the market however. Their patents for this drug expire in 2024 and in the back of the mind of the CEO is the fact, their drug ME344 is not best in best in class.






**